Ex parte Sasajima

Evidence of unexpected results relating to a property not disclosed in the original application, such as the relative toxicity of a claimed pharmaceutical compound, must still be considered in evaluating nonobviousness.

Written by

A language model, from how the MPEP uses this case rather than from the opinion.

Confidence

high — self-reported, not calibrated against a measured error rate

Human review

Not reviewed by a person

Read the opinion before relying on this in a filing. How these are made · Report an error